Which Emerging Trends Are Driving The Disseminated Intravascular Coagulation (DIC) Market Toward $0.59 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Market Size Estimates For The Disseminated Intravascular Coagulation (DIC) Market?
Over the past few years, there’s been unwavering growth in the disseminated intravascular coagulation (dic) market size. There’s an expectation for this market to escalate from $0.46 billion in 2024 to an amplified value of $0.49 billion in 2025, with a compound annual growth rate (CAGR) of 5.0%. This historical growth cycle is primarily driven by increased sepsis prevalence, a surge in trauma cases, and the escalating rate of cancer diagnoses. Additionally, higher healthcare investments, improved knowledge of healthcare professionals, and an increased adoption rate of targeted therapies have also contributed to the market’s growth.
In the coming years, the market size of disseminated intravascular coagulation (DIC) is projected to undergo consistent growth, reaching a size of $0.59 billion in 2029 with a compound annual growth rate (CAGR) of 4.9%. This growth for the forecasted period can be credited to the rising adoption of targeted therapies, an increased focus on early disease detection, investment growth in healthcare infrastructure, expansion of clinical studies on coagulopathy treatments, and a heightened awareness of rare hematological conditions. The anticipated market trends include improvement in diagnostic assays, the adoption of new anticoagulant therapies, the application of personalized medicine approaches, the integration of AI into diagnostic procedures, advancements in patient monitoring technologies, and the development of targeted treatments.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21172&type=smp
Which Growth Drivers Are Shaping The Disseminated Intravascular Coagulation (DIC) Market Outlook?
The growth of the disseminated intravascular coagulation (DIC) market is anticipated to be propelled by the escalating incidence of cancer. Defined by the unrestrained expansion and proliferation of abnormal cells that can invade and damage normal tissues, cancer is seeing a surge due to factors such as an aging populace, changes in lifestyle, exposure to environmental hazards, infections, and genetic susceptibility. Cancer can instigate disseminated intravascular coagulation (DIC) by catalyzing the overactivation of the coagulation cascade via tumor-produced procoagulant substances, which in turn leads to extensive clotting and bleeding. For example, May 2024 data from the National Cancer Institute, a US government agency, indicated that in 2022, roughly 20 million new cancer cases and 9.7 million cancer-related fatalities were reported globally. It is projected that these figures may rise to 29.9 million fresh cases and 15.3 million deaths annually by 2040. As such, the mounting occurrence of cancer is fuelling the expansion of the disseminated intravascular coagulation (DIC) market.
What Are The Primary Segmentation Parameters In The Disseminated Intravascular Coagulation (DIC) Market?
The disseminated intravascular coagulation (dic)market covered in this report is segmented –
1) By Treatment: Medicines; Transfusions; Surgery; Other Treatments
2) By Diagnosis: Complete Blood Count With Blood Smear Exam; Partial Thromboplastin Time (PTT); Fibrinogen Blood Test; D-dimer; Other Diagnoses
3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Medicines: Anticoagulants; Antiplatelet Drugs; Fibrinolytics; Procoagulants; Antithrombin Therapy
2) By Transfusions: Platelet Transfusion; Fresh Frozen Plasma (FFP); Cryoprecipitate Transfusion; Red Blood Cell Transfusion
3) By Surgery: Surgical Removal Of Thrombus; Organ Surgery
4) By Other Treatments: Plasma Exchange; Supportive Care; Steroid Therapy
Which Emerging Trends Are Reshaping The Disseminated Intravascular Coagulation (DIC) Market Landscape?
Leading organizations in the disseminated intravascular coagulation (DIC) market are advancing coagulation diagnostics with next-generation blood clotting tests to enable quicker, more accurate diagnoses and timely interventions. These advanced tests surpass conventional methods in both efficiency and detail. For instance, in June 2022, UK-based LumiraDx Limited expanded its cardiovascular diagnostics range by securing CE Mark approvals for its NT-proBNP and D-Dimer tests. These upgrades improve point-of-care diagnostic accuracy for conditions such as DIC, heart failure, and thromboembolism.
Which Organizations Are At The Forefront Of The Disseminated Intravascular Coagulation (DIC) Market?
Major companies operating in the disseminated intravascular coagulation (DIC) market are Nihon Kohden Corporation, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Danaher Corporation, Eli Lily and Company, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., Mylan N.V., Grifols S.A., Eisai Co. Ltd., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc.
Access The Complete Report Here:
Which Region Holds The Greatest Opportunity For Disseminated Intravascular Coagulation (DIC) Market Expansion?
North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2024. The regions covered in the disseminated intravascular coagulation (DIC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21172&type=smp
Browse Through More Reports Similar to the Global Disseminated Intravascular Coagulation (DIC) Market 2025, By The Business Research Company
Intravascular Catheters Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/intravascular-catheters-global-market-report
Coagulation Analyzer Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/coagulation-analyzer-global-market-report
Point Of Care Poc Coagulation Testing Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
